J. Jaime

31.7k total citations · 10 hit papers
383 papers, 24.1k citations indexed

About

J. Jaime is a scholar working on Economics and Econometrics, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J. Jaime has authored 383 papers receiving a total of 24.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Economics and Econometrics, 64 papers in Hematology and 55 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J. Jaime's work include Health Systems, Economic Evaluations, Quality of Life (77 papers), Erythropoietin and Anemia Treatment (45 papers) and Cancer, Hypoxia, and Metabolism (38 papers). J. Jaime is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (77 papers), Erythropoietin and Anemia Treatment (45 papers) and Cancer, Hypoxia, and Metabolism (38 papers). J. Jaime collaborates with scholars based in United States, Canada and United Kingdom. J. Jaime's co-authors include Susana Alicia Salceda, Simon Dagenais, Scott Haldeman, Maribel Salas, Judith A. O’Brien, Krista F. Huybrechts, О. H. Minchenko, K. Jack Ishak, Glenwood Goss and Alexandra M. Ward and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

J. Jaime

368 papers receiving 23.1k citations

Hit Papers

A systematic review of low back pain cost of illness ... 1997 2026 2006 2016 2008 1997 2013 2001 2001 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A systematic review of low back pain cost of illness studies in the United States and internationally
    2008 1.5k citations J. Jaime et al. profile →
  2. Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions
    1997 1.4k citations J. Jaime et al. profile →
  3. Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
    2013 739 citations J. Jaime et al. profile →
  4. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.
    2001 693 citations J. Jaime et al. profile →
  5. Anemia as an independent prognostic factor for survival in patients with cancer
    2001 599 citations J. Jaime et al. profile →
  6. Model Transparency and Validation
    2012 595 citations J. Jaime et al. profile →
  7. Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
    2012 524 citations J. Jaime et al. profile →
  8. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis
    2007 520 citations J. Jaime et al. profile →
  9. Modeling Good Research Practices—Overview
    2012 364 citations J. Jaime et al. profile →
  10. Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
    2012 348 citations J. Jaime et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Jaime United States 77 4.8k 4.2k 4.0k 3.4k 2.7k 383 24.1k
James F. Fries United States 79 4.3k 0.9× 1.0k 0.2× 2.2k 0.5× 8.6k 2.5× 4.6k 1.7× 249 60.5k
Catherine M. Tangen United States 57 3.8k 0.8× 3.4k 0.8× 4.6k 1.2× 883 0.3× 2.0k 0.7× 254 38.7k
Samy Suissa Canada 92 2.8k 0.6× 1.1k 0.3× 1.6k 0.4× 1.3k 0.4× 3.9k 1.4× 491 33.5k
Richard Gray United Kingdom 62 2.4k 0.5× 8.1k 1.9× 824 0.2× 1.7k 0.5× 2.0k 0.7× 204 27.6k
Dawn L. Hershman United States 82 2.3k 0.5× 3.5k 0.8× 2.4k 0.6× 1.0k 0.3× 2.0k 0.7× 717 27.2k
Andrea B. Troxel United States 71 3.6k 0.8× 1.4k 0.3× 2.0k 0.5× 708 0.2× 4.0k 1.5× 357 23.7k
Aeilko H. Zwinderman Netherlands 102 5.5k 1.2× 2.2k 0.5× 884 0.2× 1.8k 0.5× 6.0k 2.2× 669 41.7k
Bruce M. Psaty United States 110 4.1k 0.9× 1.4k 0.3× 2.6k 0.6× 2.1k 0.6× 6.4k 2.4× 642 46.3k
Mark N. Levine Canada 84 2.1k 0.4× 4.3k 1.0× 1.1k 0.3× 3.8k 1.1× 1.6k 0.6× 320 31.4k
Daniel H. Solomon United States 96 4.2k 0.9× 545 0.1× 1.9k 0.5× 2.8k 0.8× 4.1k 1.5× 585 36.0k

Countries citing papers authored by J. Jaime

Since Specialization
Citations

This map shows the geographic impact of J. Jaime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jaime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jaime more than expected).

Fields of papers citing papers by J. Jaime

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jaime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jaime. The network helps show where J. Jaime may publish in the future.

Co-authorship network of co-authors of J. Jaime

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jaime. A scholar is included among the top collaborators of J. Jaime based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jaime. J. Jaime is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Snow, Vincenza, Alejandro Cané, Paula Peyrani, et al.. (2023). 1146. Cost-effectiveness of the Pentavalent Meningococcal Vaccine (MenABCWY): A steady-state cohort modelling approach. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
3.
Vodenčarević, Asmir, et al.. (2022). Prediction of Recurrent Ischemic Stroke Using Registry Data and Machine Learning Methods: The Erlangen Stroke Registry. Stroke. 53(7). 2299–2306. 25 indexed citations
4.
Benedict, Ágnes, Emily R. Hankosky, Jieling Chen, et al.. (2022). A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes. PharmacoEconomics. 40(8). 743–750. 1 indexed citations
5.
Ferrières, Jean, Jean Dallongeville, Michel Rossignol, et al.. (2016). Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study. Journal of clinical lipidology. 10(6). 1379–1388. 2 indexed citations
6.
Civera, Miguel, et al.. (2013). Validez de la valoración subjetiva global como método de despistaje de desnutrición hospitalaria. Prevalencia de desnutrición en un hospital terciario. Endocrinología y Nutrición. 61(4). 184–189. 11 indexed citations
7.
Nishizaki, Shin-ya, Masayuki Numao, & J. Jaime. (2013). Theory and Practice of Computation: 2nd Workshop on Computation Theory and Practice, Manila, The Philippines, September 2012, Proceedings. DIAL (Catholic University of Leuven). 1 indexed citations
8.
Chen, Jersey, Chunxue Shi, Elizabeth M. Mahoney, et al.. (2011). Economic Evaluation of Clopidogrel Plus Aspirin for Secondary Prevention of Cardiovascular Events in Canada for Patients With Established Cardiovascular Disease: Results From the CHARISMA Trial. Canadian Journal of Cardiology. 27(2). 222–231. 2 indexed citations
9.
Zhang, Zefeng, Elizabeth M. Mahoney, Paul Kolm, et al.. (2010). Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers. American Journal of Cardiovascular Drugs. 10(1). 55–63. 16 indexed citations
10.
Huybrechts, Krista F., et al.. (2008). The Prognostic Value of the Modified Rankin Scale Score for Long-Term Survival after First-Ever Stroke. Cerebrovascular Diseases. 26(4). 381–387. 68 indexed citations
11.
Ward, Adrienne, et al.. (2005). Care needs and economic consequences after acute ischemic stroke: the Erlangen Stroke Project. European Journal of Neurology. 12(4). 264–267. 36 indexed citations
12.
Jaime, J., Judith A. O’Brien, Jennifer Kim, et al.. (2005). Economic Implications of Extended-Release Metoprolol Succinate for Heart Failure in the MERIT-HF Trial: A US Perspective of the MERIT-HF Trial. Journal of Cardiac Failure. 11(9). 647–656. 20 indexed citations
13.
Weintraub, William S., Elizabeth M. Mahoney, André Lamy, et al.. (2005). Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. Journal of the American College of Cardiology. 45(6). 838–845. 81 indexed citations
14.
Kolm, Paul, Emir Veledar, Zefeng Zhang, et al.. (2005). Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 46(5). 761–769. 85 indexed citations
15.
Jaime, J., Kristen Migliaccio–Walle, K. Jack Ishak, & William S. Weintraub. (2004). 889-3 Estimating life-years lost due to atherothrombotic events: Flexible survival functions for use in disease modeling. Journal of the American College of Cardiology. 43(5). A425–A425. 6 indexed citations
16.
Jaime, J.. (2001). Hypoxia Regulation of Gene Transcription. High Altitude Medicine & Biology. 2(2). 145–154. 59 indexed citations
17.
Jaime, J., Wendy S. Klittich, Alistair McGuire, et al.. (1997). The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ. 315(7122). 1577–1582. 158 indexed citations
18.
Jaime, J., Wendy S. Klittich, Alistair McGuire, et al.. (1997). The cost-effectiveness of preventing initial coronary events with pravastatin. Atherosclerosis. 134. 46–46. 3 indexed citations
19.
Jaime, J., K. M. Flegel, & Patti A. Groome. (1993). Atrial fibrillation and anticoagulation: from randomised trials to practice. The Lancet. 341(8857). 1381–1384. 27 indexed citations
20.
Erslev, Allan J., et al.. (1991). Erythropoietin life span in rats with hypoplastic and hyperplastic bone marrows. American Journal of Hematology. 36(2). 105–110. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James F. Fries Breakdown of academic impact, for papers by Catherine M. Tangen Breakdown of academic impact, for papers by Samy Suissa Breakdown of academic impact, for papers by Richard Gray Breakdown of academic impact, for papers by Dawn L. Hershman Breakdown of academic impact, for papers by Andrea B. Troxel Breakdown of academic impact, for papers by Aeilko H. Zwinderman Breakdown of academic impact, for papers by Bruce M. Psaty Breakdown of academic impact, for papers by Mark N. Levine Breakdown of academic impact, for papers by Daniel H. Solomon
Rankless by CCL
2026